Zhejiang Jingxin Pharmaceutical Co., Ltd. is a trans-regional, pharmaceutical research and development, production and sales in one of the pharmaceutical listed companies, the national key high-tech enterprises. The company's existing staff, the total, the company's headquarters is located in xinchang, in xinchang has a preparation production base, in shangyu and jiangxi has an API production base, in zhejiang hangzhou has a camp sales center, in shanghai zhangjiang hi-tech park has a r&d center, in inner mongolia bayan naoer has a traditional Chinese medicine production base.
The company's products include chemical preparations, APIs, traditional Chinese medicines, biological preparations and several other categories, including antibacterial, cardiovascular, neuropsychiatric, quinolone drugs. "Zofran hydrochloride", "cyclopropyl hydrochloride" and other raw materials and market share of domestic production and sales are among the top, the products sell well in Southeast Asia, South Asia, Latin America, Europe and other international markets, Rosuvastatin calcium raw materials and preparations have formed a large-scale production.
The company has a post-doctoral research station, Zhejiang Provincial Enterprise Research Institute and provincial technology center, and cooperation with a number of national pharmaceutical research institutions and famous universities, with strong scientific research and technological strength, research and development has achieved fruitful results, with the national key new products 7, to undertake the National Torch Plan project 7, sertraline hydrochloride was awarded the national biomedical high-tech industrial demonstration projects.
With the quality concept of "Jingxin Drug, Made with Care", the company's solid preparation production line passed the German GMP certification for the first time in 2006, passed the new version of the GMP certification in 2011, and passed the German (European Union) GMP re-certification in 2012. The APIs Simvastatin and Ciprofloxacin Hydrochloride have also obtained the COS certificates successively, and Ciprofloxacin Hydrochloride has also passed the on-site inspection by EDQM, and also obtained the French GMP certificate.
In 2008, Simvastatin tablets were exported to the UK for the first time, creating a precedent for China's finished chemical products to be exported to the high-end market in the UK; in 2009, the company realized the goal of finished products exported to Germany, and in 2012, the momentum of exponential growth in the export of preparations to further open up the European market, and the company was listed as "Excellent Export-oriented Enterprise Brand for Preparations of China's Chemical Pharmaceutical Industry". The company has also been listed as "Excellent Export-oriented Enterprise Brand of Chinese Chemical Pharmaceutical Industry Preparations" and "Pioneer Enterprise of Chinese Pharmaceutical Enterprises in Preparation Internationalization".
With the core business philosophy of "creating excellent enterprises and building a new brand of Jingxin", the company's comprehensive economic benefits have been rapidly improving, and since 2010, the company has been listed on the list of China's top 100 chemical pharmaceutical companies, and has been awarded the "Zhejiang Province 'contract-abiding, credit-guaranteeing' AAA-level enterprise". Credit' AAA Grade Enterprise of Zhejiang Province", "AAA Grade Enterprise of Tax Payment Credit Rating of Zhejiang Province", "Patent Demonstration Enterprise of Zhejiang Province", "Excellent Innovative Enterprise of Zhejiang Province", etc. The company has been honored as one of the top 100 chemical pharmaceutical enterprises in China since 2010. The company has been honored as "Excellent Innovative Enterprise of Zhejiang Province", "AAA Grade Enterprise of Tax Credit Rating of Zhejiang Province", "Patent Demonstration Enterprise of Zhejiang Province", "Excellent Innovative Enterprise of Zhejiang Province" and so on.